Skip to main content

Gastroenteropancreatic Neuroendocrine Tumor News

Related terms: GEP NETs, Gastrointestinal carcinoid

FDA Approves Lutathera (lutetium Lu 177 dotatate) for Gastroenteropancreatic Neuroendocrine Tumors

January 26, 2018 – The U.S. Food and Drug Administration today approved Lutathera (lutetium Lu 177 dotatate) for the treatment of a type of cancer that affects the pancreas or gastrointestinal tract...

Ask a question

To post your own question to this support group, sign in or create an account.